New TAVR System Promising in Pure Aortic Regurgitation

Implantation of a novel transcatheter aortic valve replacement system in patients with pure aortic regurgitation is feasible and safe, a pilot study suggests.

Related Keywords

China ,Chengdu ,Sichuan ,Gansu ,Lulu Liu ,National Research Foundation Of Nature Science ,York Heart Association ,China Hospital West School Of Medicine ,Sichuan University ,Research Letter ,Society Of Thoracic Surgeons ,West China Hospital ,Thoracic Surgeons ,New York Heart Association ,West China ,West China School ,National Research Foundation ,Nature Science , ,Aortic Insufficiency ,Transcatheter Aortic Valve Replacement Tavr ,Ranscatheter Aortic Valve Implantation Tavi ,Percutaneous Aortic Valve Replacement ,Arrhythmia ,Aortic Valve ,Hospitals ,Pacemaker ,Valve Replacement ,Heart Failure ,Heart ,Intensive Care Unit Icu ,Intensive Care Unit ,Icu ,Intensive Care ,Anatomy ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,